Prev Chronic Dis by Gwynn, R. Charon et al.
VOLUME 8: NO. 3 MAY 2011
Measures of Adiposity and Cardiovascular 
Disease Risk Factors, New York City Health 
and Nutrition Examination Survey, 2004
ORIGINAL RESEARCH
Suggested citation for this article: Gwynn RC, Berger M, 
Garg RK, Waddell EN, Philburn R, Thorpe LE. Measures 
of adiposity and cardiovascular disease risk factors, New 
York City Health and Nutrition Examination Survey, 
2004. Prev Chronic Dis 2011;8(3). http://www.cdc.gov/pcd/
issues/2011/may/10_0058.htm. Accessed [date].
PEER REVIEWED
Abstract
Introduction
Body mass index (BMI) and indicators of central adiposity 
have been associated with cardiovascular disease (CVD) 
risk factors, but ambiguity remains about which measure 
optimally predicts CVD risk and is best suited for differ-
ent racial/ethnic groups. We sought to characterize excess 
adiposity among New York City adults and assess the 
potential associations between multiple adiposity indica-
tors and CVD risk factors, by race/ethnicity.
Methods
The New York City Health and Nutrition Examination 
Survey (NYC HANES) is a population-based survey 
of noninstitutionalized New York City adult residents 
aged 20 years or older. We compared the prevalence of 
obesity (BMI ≥30 kg/m2), elevated waist circumference 
(>102 cm for men, >88 cm for women), and elevated 
waist-to-height ratio (≥0.5) for participants in the 2004 
NYC HANES (n = 1,912) and the 2003-2004 National 
Health and Nutrition Examination Survey (n = 4,075). 
Logistic regression was used to assess potential associa-
tions between each of these indicators of excess adiposity 
and CVD risk factors (diabetes, impaired fasting glucose, 
hypertension, and hypercholesterolemia), overall and by 
race/ethnicity.
Results
The prevalence of obesity among NYC HANES partici-
pants was 26% and of elevated waist circumference was 
46%, both significantly lower than national estimates (31% 
and 52%, respectively), whereas the prevalence of elevated 
waist-to-height ratio was higher (82% vs 79%). Most mea-
sures of excess adiposity were significantly associated with 
all CVD risk factors. No single measure of excess adiposity 
emerged as most consistently predictive of CVD risk in the 
general population or by race/ethnicity.
Conclusion
New York City has a lower prevalence of obesity and 
elevated waist circumference but a higher prevalence 
of elevated waist-to-height ratio than found nationally. 
Further investigation into the optimal adiposity measure 
to predict CVD risk across racial/ethnic populations may 
be warranted.
Introduction
Obesity, a body mass index (BMI) of at least 30 kg/m2, 
is a standard measure of excess adiposity used to assess 
health risk nationally and internationally. The prevalence 
of obesity has risen from 23% to 32% among US adults in 
the past decade (1) and has been linked to increases in car-
diovascular disease (CVD) risk factors (2) as well as death 
rates from CVD and all causes (3).
Although BMI is a widely accepted measure of over-
all body mass, some findings suggest that measures of 
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central adiposity have stronger associations with CVD. 
Two Australian studies found that waist-to-hip ratio 
was more strongly correlated with CVD risk than was 
BMI, waist circumference, or waist-to-height ratio (4,5). 
Alternatively, recent work indicated that waist-to-height 
ratio was more strongly associated with diabetes, hyper-
tension, and dyslipidemia than were other adiposity 
measures (6). Other studies maintain that BMI, or BMI 
in conjunction with measures of central adiposity, predicts 
CVD outcomes as well as or better than central adipos-
ity measures (7). Recent findings have not consistently 
shown a single indicator to be more highly associated with 
CVD risk, but the relationship is further complicated by 
the varying associations between adiposity measures and 
CVD risk by race/ethnicity (8). Ambiguity remains about 
which adiposity measure optimally predicts CVD risk and 
is best suited for different racial/ethnic groups.
New York City is a diverse urban community, with a 
higher percentage of black, Hispanic, and low-income 
residents — all groups with documented high prevalence 
of obesity — than national averages (1). Although recent 
studies have quantified racial/ethnic disparities in CVD 
risk factors in New York City (9,10), none has assessed the 
racial/ethnic differences in associations between multiple 
adiposity measures and CVD risk factors.
We used data from the 2004 New York City Health and 
Nutrition Examination Survey (NYC HANES) to charac-
terize excess adiposity (obesity, elevated waist circumfer-
ence, and elevated waist-to-height ratio) among New York 
City adults. We then compared local estimates to similarly 
measured national estimates by using National Health 
and Nutrition Examination Survey (NHANES) 2003-2004 
data. We further assessed the association between each 
adiposity measure and CVD risk factors, overall and by 
race/ethnicity.
Methods
NYC HANES is a population-based, cross-sectional survey 
of noninstitutionalized New York City adult residents. 
Modeled after NHANES, the 2004 NYC HANES used a 3-
stage probability design to select a representative sample 
of participants aged 20 years or older. The survey included 
a physical examination, laboratory testing, and a face-
to-face and computer-assisted self-interview. A detailed 
description of the study’s methods has been published 
elsewhere (11).
All measurements and specimen collection were conducted 
by using standardized protocols and equipment consistent 
with those used for NHANES (12). We excluded pregnant 
women (n = 29) and participants without valid anthropo-
metric values (n = 58), for a final sample of 1,912 partici-
pants. For analyses of diabetes, fasting blood glucose was 
measured from a subsample of participants who fasted for 
8 hours (n = 1,275). A detailed description of the fasting 
sample is provided elsewhere (10).
NHANES is an ongoing population-based, cross-sectional 
survey of noninstitutionalized US residents aged 2 months 
or older (12). Similar to NYC HANES, NHANES uses a 
multistage cluster sampling design. To be consistent with 
NYC HANES, we analyzed NHANES 2003-2004 data 
for adults aged 20 years or older and excluded pregnant 
women and participants without valid anthropometric 
values, for a final sample of 4,075 participants.
Participants with a BMI of at least 30 kg/m2 were classi-
fied as obese (13). We defined elevated waist circumfer-
ence as greater than 102 cm in men and greater than 88 
cm in women (13) to be consistent with cutoffs developed 
by the National Institutes of Health to identify the risk for 
obesity-related health outcomes in overweight and obese 
adults. We defined waist-to-height ratio as waist circum-
ference in centimeters divided by height in centimeters. 
Because no established cutoffs for waist-to-height ratio 
exist, we used a value of 0.5 or more, proposed by Ashwell 
and Hsieh, as being indicative of increased health risk 
across sex and race/ethnicity groups (14).
Lipid profiles were analyzed at the Lipoprotein Analytical 
Laboratory at Johns Hopkins University Hospital. Blood 
glucose levels were measured at the University of Missouri 
Diabetes Diagnostic Laboratory according to NHANES 
protocols (15).
We defined hypertension as a systolic blood pressure mea-
surement of at least 140 mm Hg or a diastolic blood pres-
sure measurement of at least 90 mm Hg or currently tak-
ing prescribed antihypertensive medications. We defined 
hypercholesterolemia as a total cholesterol measurement 
of at least 240 mg/dL or currently taking prescribed choles-
terol-lowering medications (16). We defined diabetes as a 
fasting plasma glucose measurement of at least 126 mg/dL 
or participant self-report that a health care provider had 
ever told them that they had diabetes (other than during 
pregnancy for women). Impaired fasting glucose (IFG) was 
defined as having a fasting plasma glucose measurement 
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of 100 to 125 mg/dL among participants who did not self-
report diabetes (17).
Demographic variables were age, sex, race/ethnicity, edu-
cation, income, nativity, smoking, exercise, and alcohol 
use. We defined nativity as US-born or foreign-born (par-
ticipants born in Puerto Rico, US Virgin Islands, any other 
US territory, or anywhere else other than the 50 states 
and Washington, DC). We defined exercise as vigorous 
activity (≥20 min on ≥3 d/wk), some activity, or no activity 
(18).
We categorized respondents into smokers and nonsmokers. 
Smokers were defined as respondents who reported smok-
ing at least 100 cigarettes in their life and answered “every 
day” or “some days” to the question, “Do you now smoke 
cigarettes?” Nonsmokers answered no to the question, 
“Have you smoked ≥100 cigarettes in your entire life?” or 
to the question “Do you now smoke cigarettes?” We defined 
alcohol use as heavy (≥2 drinks/d for men, ≥1 drink/d for 
women), moderate (<2 drinks/d but >12 drinks/y for men, 
<1 drink/d but >12 drinks/y for women), and low/none 
(those who had never had a drink or <12 drinks/y).
To account for differential selection probabilities and sur-
vey nonresponse we weighted participant data; weights 
were poststratified to reflect population totals. We further 
adjusted weights for item nonresponse on adiposity indica-
tors and CVD outcomes based on age group, race/ethnic-
ity, and sex. We conducted statistical analysis using SAS 
version 9.0 (SAS Institute, Inc, Cary, North Carolina) and 
used SUDAAN version 10.0 (RTI International, Research 
Triangle Park, North Carolina) to obtain standard error 
estimates and 95% confidence intervals (CIs) by Taylor 
series linearization. We age-adjusted New York City and 
national prevalence estimates to the 2000 US standard 
population aged 20 years or older (19). Significance was 
defined as P < .05. We calculated relative standard errors 
for all means and percentages; estimates with relative stan-
dard errors of more than 30% are considered unreliable. To 
test differences between NYC HANES and NHANES sur-
vey estimates, we used a linear contrast t test.
To assess associations between each adiposity measure 
and the hypertension and hypercholesterolemia outcomes 
we used logistic regression. For association between each 
adiposity measure and a 3-level indicator of glucose metab-
olism (diabetes, IFG, and normal glucose metabolism), we 
used multinomial regression. Base models included the 
CVD risk factor as the dependent variable and known 
confounders (age, sex, race/ethnicity, education, income, 
nativity, exercise, smoking, and alcohol use) as the inde-
pendent variables. We included each adiposity measure in 
a separate base model for each of 3 CVD outcomes. Models 
were also stratified by race/ethnicity.
Results
NYC HANES versus NHANES
The overall age-adjusted prevalence of obesity among 
New York City adults (26%) was significantly lower than 
the national prevalence (31%) (Table 1). The prevalence 
of obesity among New York City middle-aged adults (P = 
.02) and adults who were young, men, white, black, had 
at least a high school education, or had an annual house-
hold income of at least $20,000 (P < .01) was significantly 
lower than that of their national counterparts. The overall 
prevalence of elevated waist circumference among New 
York City adults was 46%, also significantly lower than 
the national prevalence of 52% (P < .01).
The prevalence of elevated waist-to-height ratio was 
significantly higher among New York City adults than 
among US adults (82% vs 79%, P = .03). Specifically, the 
prevalence was significantly higher among New York 
City adults aged 60 or older, women, those with at least 
a high school education, or those with an annual house-
hold income of less than $20,000 compared with adults 
nationwide (P < .05). Direct comparisons between New 
York City’s Hispanic population and that from NHANES 
are not possible because of differing regions of origin. 
However, both groups had a similarly high prevalence 
of elevated waist-to-height ratio (90% for New York City 
Hispanics vs 89% for US Mexican Americans and 83% for 
other US Hispanics).
Excess adiposity and CVD risk
Diabetes and IFG
After adjusting for covariates, we found that people with 
excess adiposity for any measure had approximately 3 
times the odds of having diabetes as those with normal 
adiposity (Table 2). Overall, obese participants and those 
with elevated waist-to-height ratio were twice as likely to 
have IFG. Among whites, both obesity and elevated waist 
circumference had large associations with diabetes (Table 
3); however, estimates had wide CIs. Among Hispanics, 
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obesity was associated with diabetes and among whites it 
was associated with IFG. Elevated waist-to-height ratio 
was significantly associated with IFG among Hispanics; 
however, CIs were wide.
Hypertension
Overall, obese participants and those with elevated waist-
to-height ratio had more than 2.5 times the odds of hav-
ing hypertension as either nonobese participants or those 
with normal waist-to-height ratios. We found a smaller 
but significant association among those with elevated 
waist circumference. We found significant associations 
for obesity and hypertension for all racial/ethnic groups. 
Elevated waist-to-height ratio was significantly associated 
with hypertension among whites and Hispanics; however, 
CIs were wide.
Hypercholesterolemia
All adiposity measures had similar associations with 
hypercholesterolemia after adjusting for covariates. 
Participants with elevated adiposity were about twice as 
likely to have hypercholesterolemia as those with normal 
measures. Whites had significantly higher odds of hyper-
cholesterolemia for obesity, elevated waist circumfer-
ence, and elevated waist-to-height ratio. Hispanics with 
elevated waist-to-height ratio were at significantly higher 
risk for hypercholesterolemia, but the CI was wide. Among 
Asians, obesity was significantly associated with hyper-
cholesterolemia.
Discussion
We observed a lower prevalence of obesity and elevated 
waist circumference in New York City than nationally but 
a higher prevalence of elevated waist-to-height ratio. In the 
New York City adult population, most measures of excess 
adiposity were significantly associated with increased odds 
of diabetes, IFG, hypertension, and hypercholesterolemia. 
No single adiposity indicator was consistently associated 
with the CVD risk factors across all racial/ethnic groups, 
but obesity was consistently associated with hypertension 
across all racial/ethnic groups. 
The lower prevalence of obesity in New York City com-
pared with the United States is notable, given that New 
York City has a larger proportion of blacks, Hispanics, 
and people of low socioeconomic status (20,21), groups that 
typically have a higher prevalence of obesity (22). Our study 
confirms higher obesity prevalence in blacks, Hispanics, 
and people of lower socioeconomic status compared with 
others in New York City, but we found that the prevalence 
of obesity and elevated waist circumference in New York 
City subgroups are both lower than found nationally. 
Lower obesity may result from New York City’s urban set-
ting; adults in the New York metropolitan area have lower 
rates than other US adults of car use and higher rates of 
active commuting (walking or bicycling to work) (23,24), 
which have been linked to increased physical activity and 
lower prevalence of excess adiposity (25). New York City 
also has a large immigrant population (nearly 40% of the 
New York City adult population is foreign-born), who have 
a lower prevalence of obesity than US-born New Yorkers.
Despite the lower prevalence of obesity and elevated waist 
circumference, we found significantly higher prevalence 
of elevated waist-to-height ratio in New York City than 
in the United States. This finding may be the result of 
the large New York City Hispanic population and its 
substantially higher waist-to-height ratios. Higher waist-
to-height values among Hispanics have been documented 
in at least 1 other study, which showed that Mexicans 
residing in Mexico City, Mexican Americans residing in 
San Antonio, Texas, and white residents from Spanish 
towns had higher mean waist-to-height ratios compared 
with non-Hispanic whites in San Antonio (26). However, 
little is known about waist-to-height ratio in Hispanic 
groups other than Mexicans. New York City Hispanics 
are primarily of Puerto Rican and Dominican descent (20), 
and, based on these findings, appear to also have higher 
waist-to-height ratio than other racial/ethnic groups.
Several studies (4-6) support our results that most adipos-
ity measures were significantly associated with increased 
odds of diabetes, IFG, hypertension, and hypercholester-
olemia. However, in race/ethnicity-specific analyses, these 
results were less consistent. Obesity was associated with 
hypertension across all racial/ethnic groups, but obesity 
and other adiposity indicators were not consistently asso-
ciated with other CVD outcomes (eg, among whites and 
Hispanics, elevated waist-to-height ratio was associated 
with both hypertension and hypercholesterolemia, but 
among blacks it was associated with diabetes). 
Previous findings have demonstrated that associations 
between adiposity measures and CVD risk differ by 
race/ethnicity. Okosun et al found that excess abdominal 
adiposity (as measured by elevated waist circumference) 
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was associated with an increased risk of prehypertension, 
hypertension, and multiple metabolic syndrome (defined 
as 2 or more of the following: hypertension, diabetes, dys-
lipidemia, hyperinsulinemia, or hypertriglyceridemia) in 
whites, blacks, and Hispanics; the associations often were 
strongest for blacks and Hispanics (27-29). Furthermore, 
Ghandehari et al found that both BMI and waist circum-
ference were associated with mean levels of fasting glu-
cose, blood pressure, and cholesterol among whites, blacks, 
and Hispanics; however, this relationship was attenuated 
among blacks compared with other racial/ethnic groups 
(30). In this study, obesity was consistently associated 
with hypertension across the racial/ethnic groups, but we 
did not find consistent associations of elevated waist cir-
cumference and obesity with all of the examined CVD risk 
factors. Differing findings may be due to the small sample 
size in our analysis, thereby limiting statistical power to 
observe significant associations.
Our analyses are based on the use of accepted or proposed 
cutoff values for each adiposity indicator. Other studies 
have assessed adiposity indicators as linear predictors 
or quartiles of linear predictors or have identified cutoffs 
based on receiver operating curves (6,31,32). For example, 
Janssen and coauthors concluded that waist circumference 
was a better predictor of health endpoints than was BMI 
when waist circumference was evaluated as a continuous 
variable (33). Our objective was not to identify optimal val-
ues for predicting CVD risk factors, but we recognize that 
the explanatory power of the adiposity indicators is limited 
by the predefined cutoff values used. Furthermore, because 
considerations such as ease of use, interpretability, cost, 
and feasibility are important criteria for acceptability (34), 
we thought that an assessment based on accepted cutoffs 
would offer the most practical application.
An additional limitation is the small sample sizes used in 
some subgroup assessments, which resulted in large CIs, 
reducing power to assess significant differences in asso-
ciations. Furthermore, NYC HANES is a cross-sectional 
survey, and causal inferences regarding the observed asso-
ciations cannot be made. Finally, data are subject to poten-
tial sources of error, including recall bias for self-reported 
information and measurement error in the examination 
components. However, standardized quality assurance 
procedures from NHANES protocols were in place to limit 
measurement error.
In summary, the prevalence of excess adiposity as mea-
sured by obesity and elevated waist circumference in New 
York City was lower than national rates. New York City 
had higher prevalence of elevated waist-to-height ratio 
compared with the United States, likely because of New 
York City’s large Hispanic population. Furthermore, our 
results show that in the general population, all 3 measures 
of excess adiposity were significantly associated with CVD 
risk factors; however, race/ethnicity-specific results were 
less consistent. Further investigation into the optimal 
adiposity measure to predict CVD risk across racial/ethnic 
populations may be warranted.
Acknowledgments
We thank Bonnie Kerker, PhD, for her insightful com-
ments and Shannon M. Farley for assistance with data 
analysis. We also thank all the staff from the New York 
City Department of Health and Mental Hygiene who 
assisted in the implementation and data collection phases 
of the survey.
Author Information
Corresponding Author: R. Charon Gwynn, PhD, Mailman 
School of Public Health, Columbia University, 722 W 
168th St, New York, NY 10032. Telephone: 212-305-9035. 
E-mail: crg2128@columbia.edu.
Author Affiliations: Magdalena Berger, Elizabeth Needham 
Waddell, Lorna E. Thorpe, New York City Department of 
Health and Mental Hygiene, New York, New York; Renu 
K. Garg, University of Washington, Seattle, Washington; 
Robyn Philburn, Forest Research Institute, New York, 
New York.
References
 1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, 
Tabak CJ, Flegal KM. Prevalence of overweight 
and obesity in the United States, 1999-2004. JAMA 
2006;295(13):1549-55.
 2. Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, 
Williams DE, Flegal KM, et al. Secular trends in 
cardiovascular disease risk factors according to body 
mass index in US adults. JAMA 2005;293(15):1868-
74.
 3. Flegal KM, Graubard BI, Williamson DF, Gail MH. 
Excess deaths associated with underweight, over-
VOLUME 8: NO. 3
MAY 2011
 Centers for Disease Control and Prevention • www.cdc.gov/pcd/issues/2011/may/10_0058.htm
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position  
of the Centers for Disease Control and Prevention.
weight, and obesity. JAMA 2005;293(15):1861-7.
 4. Chen L, Peeters A, Magliano DJ, Shaw JE, Welborn 
TA, Wolfe R, et al. Anthropometric measures and abso-
lute cardiovascular risk estimates in the Australian 
Diabetes, Obesity and Lifestyle (AusDiab) Study. Eur 
J Cardiovasc Prev Rehabil 2007;14(6):740-5.
 5. Dalton M, Cameron A, Zimmet P, Shaw J, Jolley D, 
Dunstan D, et al. Waist circumference, waist-hip ratio 
and body mass index and their correlation with car-
diovascular disease risk factors in Australian adults. 
J Intern Med 2003;254(6):555-63.
 6. Lee C, Huxley R, Wildman R, Woodward M. Indices 
of abdominal obesity are better discriminators of car-
diovascular risk factors than BMI: a meta-analysis. J 
Clin Epidemiol 2008;61(7):646-53.
 7. Gelber RP, Gaziano JM, Orav EJ, Manson JE, Buring 
JE, Kurth T. Measures of obesity and cardiisk among 
men and women. J Am Coll Cardiol 2008;52(8):605-
15.
 8. Zhu S, Wang Z, Heshka S, Heo M, Faith MS, Heymsfield 
SB. Waist circumference and obesity-associated risk 
factors among whites in the third National Health and 
Nutrition Examination Survey: clinical action thresh-
olds. Am J Clin Nutr 2002;76(4):743-9.
 9. Gwynn RC, Garg RK, Kerker BD, Frieden TR, Thorpe 
LE. Contributions of a local health examination survey 
to the surveillance of chronic and infectious diseases in 
New York City. Am J Public Health 2009;99(1):152-9.
10. Thorpe LE, Upadhyay UD, Chamany S, Garg R, 
Mandel-Ricci J, Kellerman S, et al. Prevalence and 
control of diabetes and impaired fasting glucose in 
New York City. Diabetes Care 2009;32(1):57-62.
11. Thorpe LE, Gwynn RC, Mandel-Ricci J, Roberts S, 
Tsoi B, Berman L, et al. Study design and participa-
tion rates of the New York City Health and Nutrition 
Examination Survey, 2004. Prev Chronic Dis 2006;3(3). 
http://www.cdc.gov/pcd/issues/2006/jul/05_0177.htm. 
Accessed December 27, 2010.
12. 2003-2004 National Health and Nutrition Examination 
Survey (NHANES). Centers for Disease Control 
and Prevention.  http://www.cdc.gov/nchs/nhanes/
nhanes2003-2004/current_nhanes_03_04.htm. 
Accessed February 9, 2011.
13. Clinical guidelines on the identification, evaluation, 
and treatment of overweight and obesity in adults 
— the evidence report. Obes Res 1998;6 Suppl 2:51S-
209S.
14. Ashwell M, Hsieh SD. Six reasons why the waist-to-
height ratio is a rapid and effective global indicator for 
health risks of obesity and how its use could simplify 
the international public health message on obesity. Int 
J Food Sci Nutr 2005;56(5):303-7.
15. NHANES lab methods 2003-2004. Centers for Disease 
Control and Prevention. http://www.cdc.gov/nchs/
nhanes/nhanes2003-2004/lab_methods_03_04.htm. 
Accessed December 27, 2010.
16. Ford ES, Mokdad AH, Giles WH, Mensah GA. 
Serum total cholesterol concentrations and aware-
ness, treatment, and control of hypercholesterolemia 
among US adults: findings from the National Health 
and Nutrition Examination Survey, 1999 to 2000. 
Circulation 2003;107(17):2185-9.
17. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, 
Goldstein DE, Little RR, et al. Prevalence of diabetes, 
impaired fasting glucose, and impaired glucose toler-
ance in U.S. adults. The Third National Health and 
Nutrition Examination Survey, 1988-1994. Diabetes 
Care 1998;21(4):518-24.
18. Healthy people 2010: physical activity and fitness. 
http://www.fitness.gov/digest301.pdf. Accessed 
February 12, 2009.
19. Klein RJ, Schoenborn CA. Age adjustment using the 
2000 projected U.S. population. Healthy People 2010 
Stat Notes 2001;(20):1-10.
20. New York City Department of City Planning. 
Demographic characterisitics - New York City 2000. 
http://www.nyc.gov/html/dcp/pdf/census/demonyc.pdf. 
Accessed May 8, 2007.
21. New York City Department of City Planning. 
Socioeconomic profile social characteristics - New York 
City. http://www.nyc.gov/html/dcp/pdf/census/socionyc.
pdf. Accessed May 8, 2007.
22. Hedley AA, Ogden CL, Johnson CL, Carroll MD, 
Curtin LR, Flegal KM. Prevalence of overweight and 
obesity among US children, adolescents, and adults, 
1999-2002. JAMA 2004;291(23):2847-50.
23. Table B08201. Household size by vehicles avail-
able. Washington (DC): US Census Bureau, American 
Community Survey; 2004. 
24. Journey to work: 2000. Census 2000 brief.  http://www.
census.gov/prod/2004pubs/c2kbr-33.pdf. Accessed 
February 9, 2011.
25. Frank LD, Andresen MA, Schmid TL. Obesity rela-
tionships with community design, physical activity, 
and time spent in cars. Am J Prev Med 2004;27(2):87-
96.
26. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, 
Gonzalez-Villalpando C, Williams K, Gabriel R, et 
al. Which obesity index best explains prevalence dif-
ferences in type 2 diabetes mellitus? Obesity (Silver 
VOLUME 8: NO. 3
MAY 2011
 www.cdc.gov/pcd/issues/2011/may/10_0058.htm • Centers for Disease Control and Prevention 
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position 
of the Centers for Disease Control and Prevention.
Spring) 2007;15(5):1294-301.
27. Okosun IS, Liao Y, Rotimi CN, Prewitt TE, Cooper 
RS. Abdominal adiposity and clustering of multiple 
metabolic syndrome in white, black and Hispanic 
Americans. Ann Epidemiol 2000;10(5):263-70.
28. Okosun IS, Boltri JM, Anochie LK, Chandra KM. 
Racial/ethnic differences in prehypertension in 
American adults: population and relative attribut-
able risks of abdominal obesity. J Hum Hypertens 
2004;18(12):849-55.
29. Okosun IS, Boltri JM, Hepburn VA, Eriksen MP, 
Davis-Smith M. Regional fat localization and racial/
ethnic variations in odds of hypertension in at-risk 
American adults. J Hum Hypertens 2006;20(5):362-
71.
30. Ghandehari H, Le V, Kamal-Bahl S, Bassin SL, Wong 
ND. Abdominal obesity and the spectrum of global 
cardiometabolic risks in US adults. Int J Obes (Lond) 
2009;33(2):239-48.
31. Lin W, Lee L, Chen C, Lo H, Hsia H, Liu I, et 
al. Optimal cut-off values for obesity: using simple 
anthropometric indices to predict cardiovascular risk 
factors in Taiwan. Int J Obes Relat Metab Disord 
2002;26(9):1232-8.
32. Zhu S, Heymsfield SB, Toyoshima H, Wang Z, 
Pietrobelli A, Heshka S. Race-ethnicity-specific waist 
circumference cutoffs for identifying cardiovascular 
disease risk factors. Am J Clin Nutr 2005;81(2):409-
15.
33. Janssen I, Katzmarzyk PT, Ross R. Waist circumfer-
ence and not body mass index explains obesity-related 
health risk. Am J Clin Nutr 2004;79(3):379-84.
34. Stevens J, McClain JE, Truesdale KP. Selection of 
measures in epidemiologic studies of the consequences 
of obesity. Int J Obes (Lond) 2008;32 Suppl 3:S60-6.
VOLUME 8: NO. 3
MAY 2011
8 Centers for Disease Control and Prevention • www.cdc.gov/pcd/issues/2011/may/10_0058.htm
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position  
of the Centers for Disease Control and Prevention.
Tables
Table 1. Prevalence of Indicators of Excess Adiposity, by Selected Demographic Characteristics, NYC HANES, 2004, and NHANES, 
2003-2004
Characteristic
NYC HANES NHANES
na
Obese,b % (95% 
CI)
Elevated WC,b % 
(95% CI)
Elevated WHR,b 
% (95% CI) na
Obese,b % (95% 
CI)
Elevated WC,b % 
(95% CI)
Elevated WHR,b 
% (95% CI)
Total 1,912 25. (23.1-28.3) .2 (3.5-8.9) 81.9 (9.9-83.) ,05 31.2 (28.5-33.9)c 51.9 (9.-5.5)c 8.8 (.5-80.9)c
Age, yd
20-39 938 20.2 (1.2-23.) 31.5 (2.9-35.3) 0.2 (.-3.) 1,38 2.8 (2.5-31.)c 3.8 (3.3-1.3)c 5. (2.2-8.9)
0-59 2 29.5 (25.9-33.5) 52.8 (8.8-5.8) 8.9 (81.8-8.) 1,21 35.9 (32.0-39.9)c 5.8 (5.5-1.0)c 8. (81.0-8.8)
≥60 2 28. (23.0-3.8) 0.8 (5.-.) 9.9 (9.1-98.) 1, 29. (2.5-32.) .8 (2.8-0.) 91.8 (89.-93.8)c
Sex
Male 809 22.1 (19.0-25.) 25.9 (22.-29.5) 8.0 (.-80.9) 2,059 30.0 (2.0-33.1)c 2. (39.9-.9)c 80.5 (8.0-82.9)
Female 1,103 28.8 (25.-32.) 3. (0.1-.2) 85.1 (83.0-8.0) 2,01 32.3 (28.-3.1) 1.0 (5.1-.8) .2 (3.-80.3)c
Race/ethnicity
Non-Hispanic 
white
58 21.9 (18.2-2.0) 2.8 (38.-.3) 9.8 (.5-82.8) 2,159 29.8 (2.0-32.8)c 51. (8.0-55.3)c .3 (.2-80.0)
Non-Hispanic 
black
13 32.1 (2.8-38.0) 51. (.0-5.3) 9.3 (5.-82.5) 829 3.9 (39.-8.5)c 5. (5.-0.)c 80.0 (.8-82.8)
Non-Hispanic 
Asian
253 . (.0-10.) 2. (20.1-3.) .1 (.8-9.5) NA NA NA NA
Hispanic 38 32.5 (28.2-3.2) 5. (50.2-59.0) 89.9 (88.0-91.5) NA NA NA NA
Non-Hispanic 
other
2 21.1 (10.3-38.)e 33.9 (1.3-5.)e 9. (.-8.8)e 11 13. (8.5-21.3) 33. (2.3-.) 3.3 (2.3-82.0)
Mexican 
American
NA NA NA NA 81 3. (32.1-1.0) 5.8 (9.3-0.2) 89. (8.1-91.9)
Other Hispanic NA NA NA NA 130 28. (19.3-0.3) 50.8 (2.-58.9) 82.8 (.0-8.)
Education
<High school 50 33.2 (28.5-38.2) 52. (.-5.) 85.8 (82.0-88.9) 2,199 33.5 (31.0-3.2) 5.3 (51.5-5.0) 82. (9.0-85.8)
≥High school 1,35 22. (19.9-25.) 3. (0.-.) 80. (8.2-82.) 1,82 29. (2.0-33.0)c 50.0 (.2-53.8)c .0 (3.3-8.5)c
Annual household income, $
<20,000 1 2.3(23.5-31.) .0 (2.-51.) 8.0 (81.0-8.) 1,29 30. (2.1-3.3) 52.2 (9.2-55.2) .2 (3.-80.)c
≥20,000 1,239 25.2 (22.0-28.) 5. (2.2-9.0) 81.2 (8.9-83.3) 2,89 31.1 (2.9-3.5)c 51.9 (8.8-55.0)c 9.5 (.0-81.9)
Nativity
US-born 851 30.0 (2.1-3.1) 8. (.-52.) 81.2 (8.-83.5) 3,220 32. (29.9-35.) 53. (51.1-5.) 8. (.3-80.9)
Foreign-bornf 1,055 21.9 (18.9-25.1) .0 (0.-.5) 82.5 (9.9-8.8) 85 22.9 (18.8-2.) 1.9 (3.1-.0) 9.0 (5.-82.1)
 
Abbreviations: NYC HANES, New York City Health and Nutrition Examination Survey; NHANES, National Health and Nutrition Examination Survey; CI, confidence 
interval; WC, waist circumference; WHR, waist-to-height ratio; NA, not assessed. 
a Total may not equal the sum of subgroups because of missing data. 
b Obesity defined as ≥30 kg/m2. Elevated waist circumference defined as >102 cm for men, >88 cm for women. Elevated waist-to-height ratio defined as ≥0.5. 
c Significant difference between NYC HANES and NHANES at P < .05. 
d Estimates are not age-adjusted. 
e The relative standard error for this estimate was >30% or the denominator was <50, indicating that it may be unstable and should be interpreted with caution. 
f Participants born in Puerto Rico, US Virgin Islands, any other US territory, or anywhere other than the 50 states and Washington, DC.
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Table 2. Odds of Associations Between Indicators of Excess Adiposity and Risk Factors for Cardiovascular Disease, NYC HANES, 
2004
Indicatora ORb (95% CI) AORc (95% CI)
Diabetes,d n = 1,253
Obese 3.2 (2.0-5.2) 3.5 (2.0-.3)
Elevated waist circumference 3.0 (1.9-.8) 3.3 (1.8-.0)
Elevated waist-to-height ratio 5.2 (2.-11.) 3.0 (1.2-.2)
Impaired fasting glucose,d n = 1,253
Obese 2.1 (1.5-3.0) 2. (1.-3.5)
Elevated waist circumference 1.3 (1.0-1.9) 1.5 (1.0-2.3)
Elevated waist-to-height ratio 2. (1.-.2) 2.1 (1.3-3.)
Hypertension,e n = 1,811
Obese 2. (1.9-3.0) 2. (1.9-3.)
Elevated waist circumference 2.3 (1.8-3.0) 1.5 (1.1-2.2)
Elevated waist-to-height ratio 5.9 (3.-9.) 2. (1.5-.)
Hypercholesterolemia,f n = 1,646
Obese 1.8 (1.3-2.) 1.9 (1.3-2.)
Elevated waist circumference 2.2 (1.-2.9) 1.9 (1.3-2.9)
Elevated waist-to-height ratio 3.3 (2.2-.8) 2.3 (1.5-3.5)
 
Abbreviations: NYC HANES, New York City Health and Nutrition Examination Survey; OR, odds ratio; CI, confidence interval; AOR, adjusted odds ratio. 
a Obesity defined as body mass index ≥30.0 kg/m2 (reference <30 kg/m2). Elevated waist circumference defined as >102 cm for men (reference ≤102 cm) 
and >88 cm for women (reference ≤88 cm). Elevated waist-to-height ratio defined as ≥0.5 (reference <0.5).  
b Not adjusted for covariates in base model. 
c Adjusted for covariates in base model. 
d Results from a multinomial model with 3 levels (diabetes, impaired fasting glucose, normal). Base model accounts for age, sex, race/ethnicity, education, 
income, exercise, and nativity. 
e Base model accounts for age, sex, race/ethnicity, education, income, exercise, nativity, smoking, and alcohol use. 
f Base model accounts for age, sex, race/ethnicity, education, income, exercise, nativity, and smoking.
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Table 3. Odds of Associations Between Indicators of Excess Adiposity and Risk Factors for Cardiovascular Disease, by Race/Ethnicity, 
NYC HANES, 2004
Indicatora
Race/Ethnicity
Non-Hispanic White Non-Hispanic Black Asian Hispanic
n AOR (95% CI) n AOR (95% CI) n AOR (95% CI) n AOR (95% CI)
Diabetesb
Obese 33 1.3 (5.0-59.2) 29 1.1 (0.5-2.) 152 2.3 (0.3-1.1) 59 2. (1.1-5.5)
Elevated waist circumference 33 .3 (2.-22.) 29 1. (0.-.) 152 3. (0.5-25.) 59 2.2 (0.-.)
Elevated waist-to-height ratio 33 3.5 (0.-38.) 29 3.1c (1.0-9.1) NAd NC  0.8 (0.2-2.9)
Impaired fasting glucoseb
Obese 33 5.2 (2.5-10.9) 29 1. (0.-2.) 152 1.5 (0.3-.) 59 1.9 (0.9-3.8)
Elevated waist circumference 33 1.5 (0.-3.1) 29 1.8 (0.-.3) 152 2.2 (0.-.2) 59 1.5 (0.8-2.9)
Elevated waist-to-height ratio 33 1.8 (0.8-.0) 29 3.0 (0.9-9.) NAd NC 59 9.0 (2.-31.)
Hypertensione
Obese 52 2. (1.3-.) 39 2. (1.-.5) 238 3.5 (1.1-11.2) 15 3.2 (1.-5.9)
Elevated waist circumference 52 1.9 (1.0-3.) 39 1. (0.8-3.) 238 1.0 (0.-2.5) 15 1. (0.8-2.5)
Elevated waist-to-height ratio 52 3.1 (1.1-9.0) 39 2.3 (1.0-5.5) 238 1.2 (0.5-3.3) 15 5. (1.-23.)
Hypercholesterolemiaf
Obese 88 2.0 (1.1-3.5) 35 2.1 (1.0-.) 212 5.3 (1.2-23.) 589 1. (0.9-2.9)
Elevated waist circumference 88 2.3 (1.2-.3) 35 2.3 (0.8-.) 212 2.0 (0.9-.8) 589 1. (0.9-2.8)
Elevated waist-to-height ratio 88 2.8 (1.-5.9) 35 1. (0.5-3.) 212 2.0 (0.8-5.2) 589 5. (1.9-1.3)
 
Abbreviations: NYC HANES, New York City Health and Nutrition Examination Survey; AOR, adjusted odds ratio; CI, confidence interval; NA, not applicable; NC, 
not calculated. 
a Obesity defined as body mass index ≥30.0 kg/m2 (reference <30 kg/m2). Elevated waist circumference defined as >102 cm for men (reference ≤102 cm) 
and >88 cm for women (reference ≤88 cm). Elevated waist-to-height ratio defined as ≥0.5 (reference <0.5). 
b Results from a multinomial model with 3 levels (diabetes, impaired fasting glucose, normal). Base model accounts for age, sex, race/ethnicity, education, 
income, exercise, and nativity. 
c Odds are significant at P =.0; the CI includes 1 because of rounding. 
d Value could not be calculated because no Asians with a normal waist-to-height ratio had diabetes or impaired fasting glucose. 
e Base model accounts for age, sex, race/ethnicity, education, income, exercise, nativity, smoking, and alcohol use. 
f Base model accounts for age, sex, race/ethnicity, education, income, exercise, nativity, and smoking.
